2019
DOI: 10.1148/radiol.2019190248
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional US Fractional Moving Blood Volume: Validation of Renal Perfusion Quantification

Abstract: N umerous pathologic states are characterized by altered vascularity (number of blood vessels per unit tissue volume) or perfusion (expressed as volume blood flow [in milliliters per second] per unit tissue mass [in milliliters per kilogram per second]). No easily available clinical tool exists for quantification of tissue or organ blood flow and perfusion.Perfusion estimation with use of near-infrared spectroscopy, MRI, or CT has been attempted, but there are several challenges for clinical adoption. Near-inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 28 publications
(30 reference statements)
0
21
0
Order By: Relevance
“…Among the limitations of the present pilot study, the inclusion of a single light smoker (even though CPPD variations at the implant-and palatal donor site did not show a substantial difference compared to the other subjects) have to be noted. In addition, although the presented method has already been shown to be reliable and it has been validated in the medical field (Carson et al, 1998;Fleischer et al, 1999;Gao et al, 2013;Welsh et al, 2019), future studies comparing power Doppler US and other techniques, such as fluorescein angiography or laser-Doppler flowmetry, for tissue perfusion evaluation at implant and palatal sites are needed. Future studies may benefit from power Doppler US for evaluating tissue perfusion during different phases of periodontal/ peri-implant healing, diagnosis of pathological conditions or subclinical inflammation.…”
Section: F I G U R Ementioning
confidence: 99%
See 3 more Smart Citations
“…Among the limitations of the present pilot study, the inclusion of a single light smoker (even though CPPD variations at the implant-and palatal donor site did not show a substantial difference compared to the other subjects) have to be noted. In addition, although the presented method has already been shown to be reliable and it has been validated in the medical field (Carson et al, 1998;Fleischer et al, 1999;Gao et al, 2013;Welsh et al, 2019), future studies comparing power Doppler US and other techniques, such as fluorescein angiography or laser-Doppler flowmetry, for tissue perfusion evaluation at implant and palatal sites are needed. Future studies may benefit from power Doppler US for evaluating tissue perfusion during different phases of periodontal/ peri-implant healing, diagnosis of pathological conditions or subclinical inflammation.…”
Section: F I G U R Ementioning
confidence: 99%
“…This new scanning‐angle independent approach integrates the colour flow power spectrum which extends the dynamic range and increases the machine's sensitivity to blood flow versus the traditional mean frequency estimator that is prone to noise for reduced flow (Rubin et al, 1994; Bude et al, 1994; Newman et al, 1994). In addition, power Doppler ultrasound has advantages for blood‐flow (colour and power) quantification because of its ability to depict low‐velocity signals and multidirectional flow and its lack of aliasing (Rubin et al, 1994; Welsh et al, 2019). To compensate for possible signal attenuation due to depth and tissue inhomogeneity, a method termed fractional moving blood volume (FMBV) has been established (Rubin et al, 1995; Welsh, 2004).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…There is a clinical need for a precise, fully automated, method for real-time 3D-US image segmentation which can be used to provide an estimation of placental volume and demarcate its boundaries (enable identification of the interface between placenta and uterus, thereby providing the basis for automated perfusion assessment [9], [10]). These imaging biomarkers could then be incorporated into a multi-factorial population-based screening test to improve early prediction of adverse pregnancy outcomes.…”
Section: A Clinical Motivationmentioning
confidence: 99%